Brokers│Ratings│TPs (HK$)
CLSA│Buy│687->640
Daiwa│Buy│602
CSC Financial│Buy│600
Goldman Sachs│Buy│587
JPMorgan│Overweight│580
UBS│Buy│575
Credit Suisse│Outperform│569
BofA Securities│Buy│529
Morgan Stanley│Equalweight│515
HSBC Global Research│Hold│510
Nomura│Neutral│511.8->507.5
DBS│Hold│501
Citigroup│Neutral│480
Jefferies│Hold│458.52->459.67
Brokers│Views
CLSA│NP little shy
Daiwa│at benign cycle
CSC Financial│result in-line, mid/long-term development brisk
Goldman Sachs│QoQ result beat driven by higher-than-expected investment income, good cost control
JPMorgan│earnings in-line, positive factors lasting
UBS│3Q NPAT in-line; MSCI China A 50 Connect Index futures momentum positive
Credit Suisse│QoQ result in-line, long-term outlook solid
BofA Securities│QoQ result driven by deals, yet investment weak
Morgan Stanley│rev flattish YoY, backed by strong trading rev
HSBC Global Research│near-term momentum curbed by ADT, mid-term outlook affected by rate, cost, regulation
Nomura│core biz on track, investment income weak
DBS│CN regulatory risk leads to weaker mkt investment mood
Citigroup│rev little shy, opex improves
Jefferies│QoQ result in-line
CLSA│Buy│687->640
Daiwa│Buy│602
CSC Financial│Buy│600
Goldman Sachs│Buy│587
JPMorgan│Overweight│580
UBS│Buy│575
Credit Suisse│Outperform│569
BofA Securities│Buy│529
Morgan Stanley│Equalweight│515
HSBC Global Research│Hold│510
Nomura│Neutral│511.8->507.5
DBS│Hold│501
Citigroup│Neutral│480
Jefferies│Hold│458.52->459.67
Brokers│Views
CLSA│NP little shy
Daiwa│at benign cycle
CSC Financial│result in-line, mid/long-term development brisk
Goldman Sachs│QoQ result beat driven by higher-than-expected investment income, good cost control
JPMorgan│earnings in-line, positive factors lasting
UBS│3Q NPAT in-line; MSCI China A 50 Connect Index futures momentum positive
Credit Suisse│QoQ result in-line, long-term outlook solid
BofA Securities│QoQ result driven by deals, yet investment weak
Morgan Stanley│rev flattish YoY, backed by strong trading rev
HSBC Global Research│near-term momentum curbed by ADT, mid-term outlook affected by rate, cost, regulation
Nomura│core biz on track, investment income weak
DBS│CN regulatory risk leads to weaker mkt investment mood
Citigroup│rev little shy, opex improves
Jefferies│QoQ result in-line